Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000886163-18-000098
Filing Date
2018-07-03
Accepted
2018-07-03 18:43:53
Documents
1
Period of Report
2018-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4/A  
1 PRIMARY DOCUMENT edgardoc.xml 4/A 4186
  Complete submission text file 0000886163-18-000098.txt   5632
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LIGAND PHARMACEUTICALS INCORPORATED 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121
Business Address
Gray Nancy Ryan (Reporting) CIK: 0001714949 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33093 | Film No.: 18938951